Tradestie Institutional Equity Comparison Engine

ECOR vs RCEL โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

RCEL Overall Edge

RCEL Captures Institutional Edge (3โ€“1 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Avita Medical, Inc. Common Stock (RCEL) driven by superior Valuation, Momentum & Technical, Options & Structure while ECOR counters with relative strength in Growth & Margin. Fundamentally, ECOR trades at N/M Forward P/E with -33.1% operating margin (+11.5% YoY revenue) versus RCEL at 10.3x Forward P/E and -33.9% operating margin (+53.1% YoY). In options structure, ECOR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against RCEL sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner RCEL
ECOR N/M vs RCEL 10.3x Fwd P/E
Growth & Margin Winner ECOR
Op Margin -33.1% vs -33.9% ยท YoY +11.5% vs +53.1%
Momentum & Technical Winner RCEL
1Y -9.4% vs +295.4% ยท 52W Pos 6% vs 82%
Options & Structure Winner RCEL
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (6th %ile IV)
ECOR NASDAQ
electroCore, Inc. Common Stock
Electromedical & Electrotherapeutic Apparatus
$4.42
-8.87% 1D
Market Cap $44.7M
1M Return -40.35%
1Y Return -9.43%
Forward P/E N/M
Unified AI Score
44.5 / 100 HOLD
Tech 30.0 Fund 60.0 Flow 50.0 Mom 59.0
RCEL NASDAQ
Avita Medical, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$15.62
-2.31% 1D
Market Cap $506.7M
1M Return +1.3%
1Y Return +295.44%
Forward P/E 10.3x
Unified AI Score
45.6 / 100 HOLD
Tech 32.0 Fund 44.0 Flow 69.0 Mom 31.1

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ECOR -9.43% RCEL +295.44% Spread: +304.87 pp (RCEL Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period ECOR Revenue RCEL Revenue ECOR Op. Margin RCEL Op. Margin Margin Edge
FY2018 $0M $0M -5494.1% -1489.9% RCEL
FY2019 $0M $10M -1928.2% -466.4% RCEL
FY2020 $0M $10M -707.9% -299.2% RCEL
FY2021 $10M $30M -367.7% -90.8% RCEL
FY2022 $10M $30M -266.2% -79.9% RCEL
FY2023 $20M $50M -120.2% -85.1% RCEL
FY2024 $30M $60M -48.3% -88.1% ECOR
FY2025 $30M $70M -41.1% -59.4% ECOR

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ECOR (3) vs RCEL (7)
Institutional Metric ECOR RCEL Criterion Row Winner
Market Capitalization Scale $44.7M $506.7M Larger Scale RCEL
Trailing P/E Ratio Valuation N/M 10.3x Lower Multiple RCEL
Forward P/E Ratio Valuation N/M 10.3x Lower Multiple RCEL
Revenue Growth (YoY) Growth +11.5% +53.1% Higher Growth RCEL
Operating Margin (TTM) Profitability -33.1% -33.9% Higher Margin ECOR
Net Profit Margin Profitability -33.5% -42.6% Higher Margin ECOR
Return on Equity (ROE) Capital Efficiency -478.7% -1746.3% Higher ROE ECOR
52-Week Range Position Momentum 6% ($4โ€“$13) 82% ($3โ€“$18) Stronger Trend RCEL
Beta / 30D Volatility Risk Regime 1.55ฮฒ ยท 155% Vol 1.54ฮฒ ยท 65% Vol Lower Realized Risk RCEL
Unified Institutional Score Composite Signal 44.5 / 100 (HOLD) 45.6 / 100 (HOLD) Higher Composite RCEL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ECOR vs RCEL Buy Guide
ECOR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ECOR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
RCEL CONSOLIDATION
17d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live RCEL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ECOR nor RCEL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.